Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.
Also called NCT03700801
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 130 participants
- Sponsor
- Registry
-
NCT03700801
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03700801. Non-randomized; no masking; primary purpose treatment. Start 2018-10-01 (actual); primary completion 2019-12-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Triple combination therapy group
- Intervention (Drug)
- Premixed insulin therapy group
- Lead sponsor
- Zhujiang Hospital
- Collaborator
- The Sixth Affiliated Hospital of Guangzhou Medical University
- Collaborator
- Third Affiliated Hospital, Sun Yat-Sen University
- Collaborator
- Peking University Shenzhen Hospital
- Collaborator
- Dongguan Kanghua Hospital
- Collaborator
- First People's Hospital, Shunde China
- Collaborator
- The First Affiliated Hospital of Guangdong Pharmaceutical University
- Collaborator
- The Fifth Affiliated Hospital of Zunyi Medical College
- Collaborator
- Shenzhen Sixth People's Hospital
Record details
- Record id
cardio:ct-nct03700801- Content hash
c50ae1c6220dac82bfd4c69e6660cb773af0d8964a5e71beb4dfa079992900b7